ALBEMARLE COUNTY, Va. (WVIR) – AstraZeneca’s planned move into Albemarle County is expected to bring billions of dollars in investment and hundreds of new jobs.
CvilleBioHub is working to prepare potential employees for those jobs before AstraZeneca opens its doors.
Nikki Hastings, president of CvilleBioHub, said her organization is in conversations with AstraZeneca about its plans.
“We’re in conversations, aware of what AstraZeneca is looking to do and how they plan to grow here,” Hastings said.
Hastings said those conversations are helping her team understand the skills AstraZeneca and other companies will need as the industry expands.
According to CvilleBioHub, the bioscience industry now supports about 2,100 jobs across more than 250 establishments. CvilleBioHub says industrial bioscience jobs pay an average of about $121,000 a year.
Neil Williamson, president of the Free Enterprise Forum, said that growth is part of a larger innovation corridor taking shape around Charlottesville.
“Life sciences and defense sectors are really the innovation corridor that the Central Virginia Partnership for Economic Development is talking about. Getting our workforce skilled up for those jobs is a critically important part of our task,” Williamson said.
AstraZeneca is investing $4.5 billion in a new manufacturing campus at the Rivanna Futures site in Albemarle County. The facility is expected to create about 600 permanent jobs, including engineers, scientists and process facilitators. AstraZeneca also expects about 3,000 jobs to support construction of the facility.
In a statement, AstraZeneca CEO Pascal Soriot called it the largest investment in the company’s history.
“With our $4.5 billion investment in Virginia, the largest in AstraZeneca’s history, we are not only building a state-of-the-art manufacturing facility, but also driving life sciences innovation and economic growth. This new facility will create thousands of jobs and strengthen America’s national security and health sovereignty,” Soriot said.
The need isn’t limited to AstraZeneca. Other major investments include Afton Scientific’s $200 million expansion, Bio-Cat’s fermentation facility expansion and UVA’s Manning Institute of Biotechnology.
Hastings said those jobs will require people with the right training.
“We’re discussing how the training activities for the Advanced Pharma Manufacturing Training Center will have a presence here in the Central Virginia region,” Hastings said.
The work CvilleBioHub is doing is about building a pipeline, connecting students from kindergarten through 12th grade to higher education and eventually to careers in the industry. That includes expanding internships and hands-on learning while bridging students to the technical training.
Williamson, however, questioned whether the Charlottesville-area can handle the new growth.
“The question for our community is: are we ready for those jobs? Can we position our workforce to take on these jobs, so that home-grown talent can be utilized … rather than bringing in new individuals to do that.” Williamson said.
A CvilleBioHub study found less than one-third of bachelor’s-level life sciences graduates stay in the region long-term.
Hastings said part of the work is making sure those students know there are careers for them in the region.
“What we do really well is match talent to the companies that are here, and we intend to be a strong supporter of AstraZeneca and that process,” Hastings said.
Williamson said the result could put Central Virginia on the map for more than the jobs being announced now.
“This is an innovation corridor that will begin to put Virginia on the map regarding jobs and pharmaceutical invention,” Williamson said.
The growth is something Williamson said is an opportunity for Virginia to take advantage of an industry that isn’t going away.
“Pharmaceuticals aren’t going away and pharmaceuticals are a big part of our economy so if we accept that, where should those pharmaceuticals be made? Making them in Virginia makes a lot of sense,” Williamson said.
AstraZeneca says work on the facility is starting now, with the site expected to become operational within the next few years.
Do you have a story idea? Send us your news tip here.
Copyright 2026 WVIR. All rights reserved.